Bain Capital Specialty Finance Q1 2023 Earnings Report $18.61 +0.01 (+0.03%) As of 02/21/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast Bain Capital Specialty Finance EPS ResultsActual EPS$0.50Consensus EPS $0.38Beat/MissBeat by +$0.12One Year Ago EPSN/ABain Capital Specialty Finance Revenue ResultsActual Revenue$74.74 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABain Capital Specialty Finance Announcement DetailsQuarterQ1 2023Date5/9/2023TimeN/ABCSF Upcoming EarningsBain Capital Specialty Finance will be holding an earnings conference call on Friday, February 28 at 8:00 AM Eastern. Interested parties can register for or listen to the call or dial in at 412-317-6671 using passcode "11158241". Conference Call ResourcesSlide DeckPress ReleaseBCSF Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Bain Capital Specialty Finance Earnings HeadlinesHead to Head Analysis: Bain Capital Specialty Finance (NYSE:BCSF) versus Quantum FinTech Acquisition (NYSE:QFTA)February 18, 2025 | americanbankingnews.comBain Capital Specialty Finance (NYSE:BCSF) vs. Goldenstone Acquisition (NASDAQ:GDST) Critical ContrastFebruary 18, 2025 | americanbankingnews.comBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.February 22, 2025 | InvestorPlace (Ad)Bain Capital Ventures-backed startup Index raises $2 million to build product management toolsFebruary 11, 2025 | businessinsider.comM&A News: Bain Capital Buys 350-Year-Old Japanese Drugs Firm for $3.4 billionFebruary 7, 2025 | markets.businessinsider.comBain Capital Specialty Finance issues $350M in senior notesFebruary 6, 2025 | msn.comSee More Bain Capital Specialty Finance Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bain Capital Specialty Finance? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bain Capital Specialty Finance and other key companies, straight to your email. Email Address About Bain Capital Specialty FinanceBain Capital Specialty Finance (NYSE:BCSF) is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.View Bain Capital Specialty Finance ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
